Examining the Relationship Between Vitamin D and Progressive Multiple Sclerosis
Vitamin D deficiency is a risk factor for multiple sclerosis.
ACTRIMS Forum 2018
Quality of Life in Relapsing vs Progressive Multiple Sclerosis
Data obtained from the iConquerMS network highlight areas of quality of life that affect people with relapsing and progressive forms of MS and provide substantial basis for future research.
Motivating Patients With Multiple Sclerosis May Improve Treatment Adherence, Outcomes
Patients with multiple sclerosis who were motivated to remain adherent to treatment experienced overall better outcomes, including low relapse rates.
Screening for Comorbid Psychiatric Conditions in MS: Use of Validated Screening Tools
Barriers to using screening tools included lack of time and lack of insurance compensation.
Case Study: Improving Medication Adherence in MS Patients With Cognitive Deficits
Poor medication timing, incorrect doses, medication disorganization, and under- or over-medication are some of the medication adherence issues that can occur in patients with MS and cognitive symptoms.
Multiple Sclerosis Disability, Fatigue Reduced With Caffeine Intake
The association suggests that caffeine consumption may play a protective role against multiple sclerosis-related disability.
Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder Disability Linked to Fatty Acid Intake
Intakes of fats and types of fatty acids may affect disability severity in multiple sclerosis and neuromyelitis optica spectrum disorder.
Stable Disability in Progressive Multiple Sclerosis With Teriflunomide
A significant unmet need remains for an effective, well-tolerated, and convenient treatment for patients with progressive forms of MS.
Annualized Relapse Rates Compared Among 3 RRMS Therapies
The EFFECT study compared the efficacy of dimethyl fumarate vs other disease-modifying therapies, including fingolimod and glatiramer acetate in patients with relapsing-remitting multiple sclerosis.
Case: High-Dose Biotin Leading to Pseudohyperthyroidism in Multiple Sclerosis
A 55-year-old woman with multiple sclerosis and no history of thyroid disease developed lab abnormalities suggestive of thyrotoxicosis on routine testing.
-
Loading...
-
Loading...
Next post in ACTRIMS 2018
